Correction to: Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO‑DA, DONA, and cC6O4

Detalles Bibliográficos
Autores principales: Frigerio, Gianfranco, Cafagna, Simone, Polledri, Elisa, Mercadante, Rosa, Fustinoni, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821506/
https://www.ncbi.nlm.nih.gov/pubmed/35031817
http://dx.doi.org/10.1007/s00216-022-03873-3
_version_ 1784646415022030848
author Frigerio, Gianfranco
Cafagna, Simone
Polledri, Elisa
Mercadante, Rosa
Fustinoni, Silvia
author_facet Frigerio, Gianfranco
Cafagna, Simone
Polledri, Elisa
Mercadante, Rosa
Fustinoni, Silvia
author_sort Frigerio, Gianfranco
collection PubMed
description
format Online
Article
Text
id pubmed-8821506
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-88215062022-02-23 Correction to: Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO‑DA, DONA, and cC6O4 Frigerio, Gianfranco Cafagna, Simone Polledri, Elisa Mercadante, Rosa Fustinoni, Silvia Anal Bioanal Chem Correction Springer Berlin Heidelberg 2022-01-14 2022 /pmc/articles/PMC8821506/ /pubmed/35031817 http://dx.doi.org/10.1007/s00216-022-03873-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Frigerio, Gianfranco
Cafagna, Simone
Polledri, Elisa
Mercadante, Rosa
Fustinoni, Silvia
Correction to: Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO‑DA, DONA, and cC6O4
title Correction to: Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO‑DA, DONA, and cC6O4
title_full Correction to: Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO‑DA, DONA, and cC6O4
title_fullStr Correction to: Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO‑DA, DONA, and cC6O4
title_full_unstemmed Correction to: Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO‑DA, DONA, and cC6O4
title_short Correction to: Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO‑DA, DONA, and cC6O4
title_sort correction to: development and validation of an lc–ms/ms method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (pfass) in human plasma, including hfpo‑da, dona, and cc6o4
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821506/
https://www.ncbi.nlm.nih.gov/pubmed/35031817
http://dx.doi.org/10.1007/s00216-022-03873-3
work_keys_str_mv AT frigeriogianfranco correctiontodevelopmentandvalidationofanlcmsmsmethodforthequantitationof30legacyandemergingperandpolyfluoroalkylsubstancespfassinhumanplasmaincludinghfpodadonaandcc6o4
AT cafagnasimone correctiontodevelopmentandvalidationofanlcmsmsmethodforthequantitationof30legacyandemergingperandpolyfluoroalkylsubstancespfassinhumanplasmaincludinghfpodadonaandcc6o4
AT polledrielisa correctiontodevelopmentandvalidationofanlcmsmsmethodforthequantitationof30legacyandemergingperandpolyfluoroalkylsubstancespfassinhumanplasmaincludinghfpodadonaandcc6o4
AT mercadanterosa correctiontodevelopmentandvalidationofanlcmsmsmethodforthequantitationof30legacyandemergingperandpolyfluoroalkylsubstancespfassinhumanplasmaincludinghfpodadonaandcc6o4
AT fustinonisilvia correctiontodevelopmentandvalidationofanlcmsmsmethodforthequantitationof30legacyandemergingperandpolyfluoroalkylsubstancespfassinhumanplasmaincludinghfpodadonaandcc6o4

Ejemplares similares